Govt policy boosts Samaiden's transition to RE asset owner
The award of three new bioenergy assets – two biomass and one biogas plants – signals continued momentum in Samaiden's transition from an engineering, procurement, construction and commissioning (EPCC) contractor to an RE asset owner.
'We reiterate our positive stance on Samaiden's outlook following its latest win, which reinforces the group's strong position in the RE space,' said the research house.
The new plants, awarded to Samaiden's subsidiaries Legasi Green Resources Sdn Bhd (88%-owned), Sumas Energy Sdn Bhd (51%) and SC Green Solutions Sdn Bhd (100%), collectively adds 18MW of installed capacity to the group's portfolio.
They will be developed under a 21-year power purchase agreement (PPA), with the FiT 2.0 scheme offering a fixed tariff for the first 10 years, and a bidding-based mechanism thereafter.
'These assets further strengthen Samaiden's diversified RE portfolio – spanning solar, biogas, and biomass – and underscore its growing role in driving Malaysia's clean-energy transition,' said RHB Research in a note to clients yesterday.
While earnings estimates remain unchanged for now, back-of-envelope calculations by RHB Research suggest the trio of plants could add around RM11mil to annual earnings, based on effective equity stakes.
'Management is guiding for a high single-digit to low double-digit internal rate of return (IRR),' said the research house, adding that capital expenditure for the plants is generally estimated at RM10mil to RM12mil per megawatt.
The facilities are expected to be running by 2028.
In addition to its asset-building plans, Samaiden also stands to benefit from EPCC contracts related to other shortlisted FiT 2.0 projects, with RHB Research noting potential upside to its valuation as contributions from these new bioenergy projects and Samaiden's large scale solar 5 (LSS5) asset are not yet included in the research house's base case.
Seeing potential upside to its valuation of the stock, which had risen 24.8% in the last month, RHB Research is forecasting recurring net profit for Samaiden to rise 24.2% for its financial year ended June 2025 (FY25) and 41.6% in FY26.
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
New Straits Times
6 hours ago
- New Straits Times
IOI Corp upstream earnings strong amid CPO gains, says RHB
KUALA LUMPUR: IOI Corp Bhd's upstream earnings are expected to continue doing well on the back of elevated crude palm oil (CPO) prices, while the company is embarking on new ventures to diversify its income streams, said RHB Research. IOI achieved fresh fruit bunch (FFB) growth in the financial year 2025 (FY25) of 1.3 per cent year on year (YoY), below its original target of 3 per cent. While output saw a mini-peak in April, IOI expects production to pick up again in July, with a bigger peak in August-September. "For FY26, it expects FFB output growth of 3-5 per cent from better weather conditions. This is in line with our 4 per cent forecast," RHB Research said in a note. Featured Videos Meanwhile, the firm noted that IOI is excited about its 33 per cent stake in a new pulp and paper joint venture using oil palm empty fruit bunches (EFB) with Nextgreen Global (NGGB MK, NR) to produce renewable pulp and paper products in Pekan. RHB Research noted that the first phase of the plant (150,000 tonnes) should be operational by 2028, with a potential earnings before interest and taxes (EBIT) contribution of about RM30 to RM50 million. It said IOI has also ventured into the coconut plantation business, planting some 3,500 ha of its peripheral landbank (target 4,600 ha) with coconut trees. "This is expected to bring in an EBIT of RM60 million to RM70 million based on current coconut prices and full maturity of trees. "Overall, we keep Buy on the stocks with a target price of RM4.30," it added.
The Star
9 hours ago
- The Star
IOI's upstream earnings to ride on strong CPO prices
PETALING JAYA: IOI Corp Bhd is expected to deliver stronger earnings in the coming financial years as it benefits from elevated crude palm oil (CPO) prices while pursuing fresh income streams through new ventures and mergers and acquisitions. The group is also targeting fresh fruit bunches (FFB) output growth and cost containment measures that could support margins going forward. According to RHB Research, which met with IOI Corp's management recently, the outlook remains positive as upstream earnings will continue doing well on strong CPO prices. This is further supported by the group's embarking on new ventures to diversify its income streams. The brokerage said the group's valuation was still appealing, trading at 17.5 times its forecast price-earnings ratio for 2026, at the lower end of the 17 to 22 times range of peers. On production, RHB Research noted that IOI achieved FFB growth of 1.3% year-on-year (y-o-y) in the financial year (FY) ended June 30, 2025, below its initial 3% target. 'While output saw a mini peak in April, IOI expects production to pick up again in July, with a bigger peak in August-September,' it said. For FY26, the group was targeting FFB output growth of 3-5% on the back of better weather conditions, in line with RHB Research's 4% forecast. The company was also expected to keep unit costs in check. 'IOI expects FY25 costs to come in at around RM2,000-RM2,100 per tonne (flattish y-o-y),' RHB Research said, adding that it had already secured fertiliser requirements for the first half of FY26 at flat prices y-o-y. However, a 2-3% rise in costs could result from minimum wage adjustments and Employees Provident Fund contribution requirements. On regulatory risks, RHB Research said IOI would face minimal impact from the government's sales and service tax (SST) and US tariffs. The group had obtained SST exemptions for its oleochemicals operations and over 90% of its trading volumes comprised CPO and palm olein, which were not subjected to the tax. 'There is no significant impact to IOI as 90% of Malaysian CPO production is exported to the European Union as certified products, with less than 2% exported to the United States,' it added. Looking ahead, IOI Corp was actively seeking brownfield upstream landbanks in Malaysia and Indonesia and opportunities in specialty oleochemicals for the pharmaceutical and personal care sectors. It also expressed excitement over its 33% stake in a pulp and paper joint venture with Nextgreen Global Bhd to turn oil palm empty fruit bunches into renewable products. 'The first phase of the plant (150,000 tonnes) should be operational by 2028, with potential earnings before interest and tax (ebit) contribution of RM30mil-RM50mil,' RHB Research said. The group's diversification efforts extended to coconut plantations, where 3,500 hectares had already been planted, targeting 4,600 hectares in total. This business could bring in RM60mil-RM70mil in ebit at full maturity. RHB Research reiterated its 'buy' call on IOI, maintaining a sum-of-parts-based target price of RM4.30 with a 2% environmental, social and governance premium.
The Star
14 hours ago
- The Star
DXN to be driven by its expansion plans
Maybank IB Research believes DXN's growth prospects lie in its continued geographic expansion into Brazil and Argentina. PETALING JAYA: Analysts are upbeat about DXN Holdings Bhd 's growth prospects despite its first-quarter earnings coming in below expectations. According to RHB Research, the company is attractive in terms of valuations, given that its business will be driven by its expansion plans and healthy cash flow generation. 'DXN's earnings growth will be supported by the relentless growth momentum in major markets. The core strategies to recruit new members and enhance the members' productivity will continue to revolve around member engagements, complemented by quality new product launches,' it explained. The research house added that the recent capacity expansion could help the company to capture the rising demand and roll out new product categories to broaden the addressable markets. 'The consequent efficiency gain together with annual price adjustments will sustain the high gross profit margin of 80%, notwithstanding the rising input and overhead costs,' it said. The research house expected a significant earnings contribution from its venture into Brazil in the next three to four years, leveraging on DXN's existing network in the Latin American region. It maintained a 'buy' call on the stock but with a lower target price of 80 sen (from 88 sen), signifying a 58% upside and 7% financial year 2026 yield. RHB Research said the valuation was below the consumer sector average to take into account the highly regulated direct selling industry DXN is in. The research house pointed out that DXN's results for the first quarter of FY26 (1Q26) missed forecasts due to unfavourable foreign exchange (forex) movements and ongoing currency crisis in Bolivia, which is a key market. It said DXN's net profit of RM74mil, down 14% year-on-year (y-o-y), met only 19% of the research house's and consensus forecasts, mainly due to the unfavourable forex, prompting it to cut FY26 to FY28 earnings by 9%, 6% and 5%, respectively. Maybank Investment Bank Research has kept its 'buy' call and target price of 72 sen as well as its FY26 to FY28 earnings estimates unchanged, pending DXN's 1Q26 results briefing. It said DXN's 1Q26 results came in below expectations mainly due to lower-than-expected sales on unfavourable forex movements against the ringgit. Similarly, Maybank Investment Bank Research has kept its 'buy' call and target price of 72 sen as well as its FY26–FY28 earnings estimates unchanged, pending DXN's 1QFY26 results briefing. It said DXN's 1QFY26 results came in below expectations mainly due to lower-than-expected sales on unfavourable forex movements against the ringgit. 'We caution that the persistent strength in the ringgit may continue to suppress the group's overall sales growth potential. 'Pressure on DXN's overall sales may persist if the ringgit continues to strengthen against the currencies of its core markets (like Latin America), given that its sales in Malaysia is estimated to account for 10% of total group sales, with the remainder in foreign currency,' Maybank IB Research said. Nevertheless, the research house believes DXN's growth prospects lie with its continued geographic expansion into Brazil and Argentina, which it hopes to replicate the successes it achieved in Peru and Bolivia.
